2,454
Views
4
CrossRef citations to date
0
Altmetric
Nephrology

Regional variations in prevalence and severity of autosomal dominant polycystic kidney disease in the United States

, , , , , & show all
Pages 1155-1162 | Received 08 Mar 2021, Accepted 05 May 2021, Published online: 25 May 2021

Figures & data

Figure 1. Sample selection criteria. Abbreviations. ADPKD, autosomal dominant polycystic kidney disease; CKD, chronic kidney disease; ICD-10-CM, International Classification of Diseases, 10th Revision, Clinical Modification. Note: 1. The period over which prevalence was calculated spanned from 01/01/2017 to 12/31/2017 for the annual prevalence, and from 01/01/2016 to 12/31/2017 for the two-year prevalence.

Figure 1. Sample selection criteria. Abbreviations. ADPKD, autosomal dominant polycystic kidney disease; CKD, chronic kidney disease; ICD-10-CM, International Classification of Diseases, 10th Revision, Clinical Modification. Note: 1. The period over which prevalence was calculated spanned from 01/01/2017 to 12/31/2017 for the annual prevalence, and from 01/01/2016 to 12/31/2017 for the two-year prevalence.

Table 1. Characteristics of individuals diagnosed with ADPKD.

Figure 2. Annual prevalence and two-year prevalence of ADPKD and ADPKD at risk of rapid progression by census region. Abbreviations. ADPKD, autosomal dominant polycystic kidney disease.

Figure 2. Annual prevalence and two-year prevalence of ADPKD and ADPKD at risk of rapid progression by census region. Abbreviations. ADPKD, autosomal dominant polycystic kidney disease.

Figure 3. Two-year ADPKD prevalence by US state. Abbreviations. ADPKD, autosomal dominant polycystic kidney disease; US, United States.

Figure 3. Two-year ADPKD prevalence by US state. Abbreviations. ADPKD, autosomal dominant polycystic kidney disease; US, United States.
Supplemental material

Supplemental Material

Download MS Word (19 KB)